Healthcare -
Biotechnology - NASDAQ - US
$ 74.17
1.57 %
$ 9.55 B
Market Cap
-19.52
P/E
PCVX - LONG-TERM DEBT
Long-term Debt PCVX - Vaxcyte, Inc.
22.1 M
LAST VALUE
38.62%
2 YEAR CAGR
167.64%
5 YEAR CAGR
0.00%
10 YEAR CAGR